{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-115355","form_type":"8-K","ticker":"CBIO","cik":"0001253689","company_name":"CRESCENT BIOPHARMA, INC.","filed_at":"2024-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.916409+00:00","generated_at":"2026-05-30T03:19:21.461229+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"GlycoMimetics and Crescent update merger investor presentation; no new deal terms disclosed","bullets":["GlycoMimetics furnished updated investor presentation (Exhibit 99.1) for proposed merger with Crescent Biopharma.","Presentation dated November 2024 contains no new financial terms, valuation, or timeline.","No changes to previously announced merger agreement structure or closing conditions were disclosed."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-115355","json":"https://secwatch.observer/filing/0001104659-24-115355.json","markdown":"https://secwatch.observer/filing/0001104659-24-115355.md","text":"https://secwatch.observer/filing/0001104659-24-115355.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1253689/000110465924115355/0001104659-24-115355-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1253689/000110465924115355/tm2427808d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T03:19:21.461229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}